Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining -10.14% today. In the last week its performance is -8.24%, and -34.18% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 67.05, so today’s gain of -10.14% is a significant step towards its target price. The GAP today is therefore -8.37%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 82654.72, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.30%.

At the current price of 49.81, it has a dividend yield of 3.05%, and its target price is 67.05. This is with a profit margin of 16.30%, and total debt/equity of 0.45. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 29.15, as well as a forward P/E of 16.66.

With a current EPS of 1.71, and a forecasted EPS growth for next year at 13.87%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 18.53%.

Performance for the year is -16.99%. Since its IPO date on 6/1/1972, the total performance to date is -26.27%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 65198800, while its average volume is 12963.55. Whilst the total gain today was -10.14%, it did have a day high of -34.27%.

Volatility for this week has been at 1.97%, and 1.78% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been -6.36%, while the 52-week-high has reached -34.96%.

Looking at its return of investments, which is 4.60%, and its return on assets is 9.00%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 20.80%. With a sales growth of 17.00% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.44, and has a current ratio of 1.6 and 1.4 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 1.57, and the P/S is 4.69, along with a P/B of 5.58. Meanwhile it has a p/cash of 17.77.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment